Real-Time Quantitative RT-PCR to Detect Fusion Gene Transcripts Associated With AML
Relapse remains a major cause of treatment failure in acute myeloid leukemia (AML); however, patients destined to relapse cannot be reliably distinguished on the basis of pretreatment characteristics. Hence, there has been considerable interest in strategies for detection of minimal residual disease (MRD) as a means of identifying patients at high risk from relapse who could benefit from additional therapy. Moreover, MRD monitoring also affords the opportunity to reveal subsets of patients at low risk of relapse who could be spared excessive therapy, thereby reducing the risk of treatment related mortality and morbidity. Previous studies have confirmed that MRD monitoring using PCR- or flow cytometric-based approaches provides key independent prognostic information in a number of subtypes of leukemia and is increasingly being used for risk stratification as a means of directing treatment approach (see refs. 1,2 for recent reviews).
KeywordsVortex EDTA Leukemia Electrophoresis MgCl2
- 1.Foroni, L. and Hoffbrand, A. V., (eds.) (2002) Minimal residual disease investigation in haematological malignancies. Baillière Best Pract. Res. Clin. Haematol. 15, 1–195.Google Scholar
- 2.Szczepanski, T., Orfão, A., van der Velden, V. H. J., mnSan Miguel, J. F., and van Dongen, J. J. M. (2001) Minimal residual disease in leukaemia patients. Lancet Oncol. 2, 409–417.Google Scholar
- 16.Gabert, J., Beillard, E., van der Velden, V. H. J., et al. (2003) Standardization and quality control studies of “real-time” quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) of fusion gene transcripts for minimal residual disease detection in leukemia patients. Leukemia (in press).Google Scholar
- 17.Beillard, E., Pallisgaard N., van der Velden, V. H. J., et al. (2003) Evaluation of candidate control genes for “real-time” quantitative reverse-transcriptase PCR analysis of fusion gene transcripts in leukemia patients—A Europe Against Cancer Program. Leukemia (in press).Google Scholar